C Donegan

1.2k total citations
8 papers, 51 citations indexed

About

C Donegan is a scholar working on Clinical Psychology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, C Donegan has authored 8 papers receiving a total of 51 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Psychology, 2 papers in Organic Chemistry and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in C Donegan's work include Psychedelics and Drug Studies (5 papers), Neurotransmitter Receptor Influence on Behavior (2 papers) and Chemical synthesis and alkaloids (2 papers). C Donegan is often cited by papers focused on Psychedelics and Drug Studies (5 papers), Neurotransmitter Receptor Influence on Behavior (2 papers) and Chemical synthesis and alkaloids (2 papers). C Donegan collaborates with scholars based in New Zealand, Australia and Greece. C Donegan's co-authors include Desmond O’Neill, Patricia McCormack, J. Feely, Rita T. Lawlor, Susan M. Smith, J. B. Walsh, Dion F. Coakley, Alana Cavadino, Mahima Bansal and Partha S. Roop and has published in prestigious journals such as Neuropharmacology, Progress in Neuro-Psychopharmacology and Biological Psychiatry and Respiratory Medicine.

In The Last Decade

C Donegan

7 papers receiving 50 citations

Peers

Countries citing papers authored by C Donegan

Since Specialization

Citations

This map shows the geographic impact of C Donegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Donegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Donegan more than expected).

Fields of papers citing papers by C Donegan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Donegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Donegan. The network helps show where C Donegan may publish in the future.

Co-authorship network of co-authors of C Donegan

This figure shows the co-authorship network connecting the top 25 collaborators of C Donegan. A scholar is included among the top collaborators of C Donegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Donegan. C Donegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial 2026 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·(unknown), C Donegan, Rachael L. Sumner, Anna Forsyth, (unknown), (unknown), (unknown), (unknown), Lisa Reynolds, (unknown), Nathan Allen, (unknown), David B Menkes, (unknown)	1
2	LSD microdosing in major depressive disorder: results from an open-label trial 2025 ·Neuropharmacology ·Dimitri Daldegan‐Bueno, C Donegan, Rachael L. Sumner, Anna Forsyth, William J. Evans, (unknown), Lisa Reynolds, Rhys Ponton, Thomas A. Smith, Partha S. Roop, (unknown), Nathan Allen, Frederick Sundram, David B Menkes, Suresh Muthukumaraswamy	1
3	Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures 2025 ·Neuropharmacology ·C Donegan, Dimitri Daldegan‐Bueno, Tehseen Noorani, Rachael L. Sumner, Anna Forsyth, William J. Evans, Thomas A. Smith, (unknown), Frederick Sundram, David B Menkes, Suresh Muthukumaraswamy, Lisa Reynolds	1
4	LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder 2024 ·Trials ·Dimitri Daldegan‐Bueno, C Donegan, Anna Forsyth, Rachael L. Sumner, (unknown), David B Menkes, William J. Evans, (unknown), Frederick Sundram, Lisa Reynolds, Rhys Ponton, Alana Cavadino, Thomas A. Smith, Partha S. Roop, Nathan Allen, (unknown), Darren Svirskis, Mahima Bansal, Suresh Muthukumaraswamy	9
5	Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression? 2024 ·Journal of Psychopharmacology ·Shabah M. Shadli, C Donegan, (unknown), Bruce Russell, Paul Glue, Neil McNaughton	0
6	An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1) 2023 ·Pilot and Feasibility Studies ·C Donegan, Dimitri Daldegan‐Bueno, Rachael L. Sumner, David B Menkes, William J. Evans, (unknown), Frederick Sundram, Lisa Reynolds, Rhys Ponton, Alana Cavadino, Thomas A. Smith, Partha S. Roop, Nathan Allen, (unknown), Darren Svirskis, Anna Forsyth, Mahima Bansal, Suresh Muthukumaraswamy	12
7	Knowledge and attitudes to prescribed drugs in young and elderly patients. 1997 ·PubMed ·Patricia McCormack, Rita T. Lawlor, C Donegan, Desmond O’Neill, Susan M. Smith, (unknown), (unknown), (unknown), J. B. Walsh, Dion F. Coakley, J. Feely	19
8	Low carbon monoxide transfer factor (TlCO) in HI V-infected patients without lung disease 1992 ·Respiratory Medicine ·Patrick French, (unknown), J Fleming, C Donegan, J R Harris, Richard Shaw, David M. Mitchell	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact